Skip to main content
Premium Trial:

Request an Annual Quote

TeselaGen, Redbiotech to Co-create Herpesvirus Vaccine Library

Premium

This week, TeselaGen Biotechnology and Redbiotec announced their plans to build a library that will be used to develop vaccines for the Herpesvirus.

According to the partners, Redbiotec will contribute its proprietary rePAX technology, which is used to produce virus-like particles and multi-protein complexes and its expertise in the field of human cytomegalovirus, while TeselaGen will provide infrastructure for building and modifying DNA and automatic library creation as well as statistical learning approaches to model the performance of VLPs and multi-protein complexes and to feed such information back into the design process.

The companies' goal is to build a verified library for Herpesvirus vaccine development and testing that will help reveal potential causes of virus latency and elucidate virus-triggered cancer mechanisms. It will also enable the optimization and improvement of new and existing vaccine candidates, they said.

This is the second partnership TeselaGen has announced this year. In July, it signed a multi-year licensing agreement that allows Genomatica to use its automated DNA cloning software for microbial strain engineering projects (BI 7/12/2013).

Filed under

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.